Acute phase proteins in endemic chronic liver diseases

Area of Science:

• Immunology
• Hepatology
• Infectious Diseases

Background:

• Chronic liver disease encompasses various etiologies, including parasitic infections like schistosomiasis.
• Schistosomiasis can present as pure infection or mixed with other liver pathologies, potentially influencing disease progression.
• Acute phase proteins (APPs) are markers of inflammation and immune response, often elevated in liver disease.

Purpose of the Study:

• To investigate acute phase protein levels in patients with chronic liver disease and schistosomiasis.
• To differentiate between pure schistosomiasis and mixed schistosomal cases with chronic hepatitis or cirrhosis based on APP profiles.
• To explore the role of the immune system in the pathogenesis of mixed schistosomal liver disease.

Main Methods:

• Serum samples were collected from 40 patients with chronic liver disease and 10 healthy controls.
• Patients were categorized into pure schistosomal and mixed schistosomal groups (with chronic hepatitis or cirrhosis).
• Levels of acute phase proteins were measured and compared across the different study groups.

Main Results:

• Mixed schistosomal cases with chronic hepatitis or cirrhosis exhibited more marked changes in acute phase proteins compared to pure schistosomal cases.
• Serum levels of acute phase proteins in the pure schistosomal group were closer to normal values.
• The significant alterations in APPs in mixed groups suggest greater immune system involvement.

Conclusions:

• Acute phase protein profiles can potentially differentiate between pure and mixed schistosomal liver disease.
• Mixed schistosomal liver disease involves more significant immune system activation compared to pure schistosomiasis.
• Further research into immune system modulation is warranted for managing mixed schistosomal liver disease.